Treatment of restless legs syndrome in patients with chronic kidney disease: a focus on medications.
Raymond
Colette B
CB
Winnipeg Regional Health Authority, Manitoba Renal Program, Winnipeg, MB. craymond@exchange.hsc.mb.ca
Breland
Lance
L
Wazny
Lori D
LD
Sood
Amy R
AR
Orsulak
Cali D
CD
D015259:Dopamine Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000451:nursing; D012148:Restless Legs Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D012307:Risk Factors
D015259:Dopamine Agents; D007980:Levodopa